A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial
10.1080/03009742.2021.1901416
Saved in:
Main Authors: | YK Tan, PSE Teo, SE Saffari, Xiaohui Xin, B Chakraborty, CT Ng, J Thumboo |
---|---|
Other Authors: | DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) |
Format: | Article |
Published: |
Taylor & Francis
2022
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/214919 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
by: Worawit Louthrenoo, et al.
Published: (2018) -
2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
by: Worawit Louthrenoo, et al.
Published: (2018) -
Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis
by: Wanruchada Katchamart, et al.
Published: (2018) -
Development of an in-vitro rheumatoid arthritis (RA) model and its application in anti-rheumatic drug testing
by: Tan, Kian Siong
Published: (2016) -
Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study
by: Korawit Kanjana, et al.
Published: (2020)